Cargando…

Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran

BACKGROUND: The aim of this study was to translate the EORTC quality of life questionnaire for brain cancer, the QLQ-BN20, into Persian, and to evaluate its psychometric properties when used among brain cancer patients in Iran. METHODS: A standard backward and forward translation procedure was used...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoshnevisan, Alireza, Yekaninejad, Mir Saeed, Ardakani, Shahab Kamali, Pakpour, Amir H, Mardani, Azam, Aaronson, Neil K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422187/
https://www.ncbi.nlm.nih.gov/pubmed/22607028
http://dx.doi.org/10.1186/1477-7525-10-54
_version_ 1782241007662792704
author Khoshnevisan, Alireza
Yekaninejad, Mir Saeed
Ardakani, Shahab Kamali
Pakpour, Amir H
Mardani, Azam
Aaronson, Neil K
author_facet Khoshnevisan, Alireza
Yekaninejad, Mir Saeed
Ardakani, Shahab Kamali
Pakpour, Amir H
Mardani, Azam
Aaronson, Neil K
author_sort Khoshnevisan, Alireza
collection PubMed
description BACKGROUND: The aim of this study was to translate the EORTC quality of life questionnaire for brain cancer, the QLQ-BN20, into Persian, and to evaluate its psychometric properties when used among brain cancer patients in Iran. METHODS: A standard backward and forward translation procedure was used to generate the Persian language version of the QLQ-BN20. The QLQ-BN20 was administered together with the QLQ-C30 to 194 patients diagnosed with primary brain cancer. Multitrait scaling and confirmatory factor analysis (CFA) were used to evaluate the hypothesized scale structure of the questionnaire. Internal consistency reliability was estimated with Cronbach’s alpha. The ability of the QLQ-BN20 to distinguish between patient subgroups formed on the basis of performance status and cognitive status was evaluated, as was the responsiveness of the questionnaire to changes in performance status over time. RESULTS: Multitrait scaling and CFA results confirmed the hypothesized scale structure. The measurement model was consistent across men and women. Internal consistency reliability of the multi-item scales ranged from 0.74 to 0.89. The QLQ-BN20 distinguished clearly between patients with relatively good versus poor performance and cognitive status, and changes in scores over time reflected changes observed in performance status ratings. CONCLUSIONS: These results support the validity and reliability of the QLQ-BN20 for use among Iranian patients diagnosed with primary brain cancer. Future studies should examine the psychometrics of the questionnaire when used in patients with brain metastasis.
format Online
Article
Text
id pubmed-3422187
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34221872012-08-18 Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran Khoshnevisan, Alireza Yekaninejad, Mir Saeed Ardakani, Shahab Kamali Pakpour, Amir H Mardani, Azam Aaronson, Neil K Health Qual Life Outcomes Research BACKGROUND: The aim of this study was to translate the EORTC quality of life questionnaire for brain cancer, the QLQ-BN20, into Persian, and to evaluate its psychometric properties when used among brain cancer patients in Iran. METHODS: A standard backward and forward translation procedure was used to generate the Persian language version of the QLQ-BN20. The QLQ-BN20 was administered together with the QLQ-C30 to 194 patients diagnosed with primary brain cancer. Multitrait scaling and confirmatory factor analysis (CFA) were used to evaluate the hypothesized scale structure of the questionnaire. Internal consistency reliability was estimated with Cronbach’s alpha. The ability of the QLQ-BN20 to distinguish between patient subgroups formed on the basis of performance status and cognitive status was evaluated, as was the responsiveness of the questionnaire to changes in performance status over time. RESULTS: Multitrait scaling and CFA results confirmed the hypothesized scale structure. The measurement model was consistent across men and women. Internal consistency reliability of the multi-item scales ranged from 0.74 to 0.89. The QLQ-BN20 distinguished clearly between patients with relatively good versus poor performance and cognitive status, and changes in scores over time reflected changes observed in performance status ratings. CONCLUSIONS: These results support the validity and reliability of the QLQ-BN20 for use among Iranian patients diagnosed with primary brain cancer. Future studies should examine the psychometrics of the questionnaire when used in patients with brain metastasis. BioMed Central 2012-05-20 /pmc/articles/PMC3422187/ /pubmed/22607028 http://dx.doi.org/10.1186/1477-7525-10-54 Text en Copyright ©2012 Khoshnevisan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Khoshnevisan, Alireza
Yekaninejad, Mir Saeed
Ardakani, Shahab Kamali
Pakpour, Amir H
Mardani, Azam
Aaronson, Neil K
Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
title Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
title_full Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
title_fullStr Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
title_full_unstemmed Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
title_short Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
title_sort translation and validation of the eortc brain cancer module (eortc qlq-bn20) for use in iran
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422187/
https://www.ncbi.nlm.nih.gov/pubmed/22607028
http://dx.doi.org/10.1186/1477-7525-10-54
work_keys_str_mv AT khoshnevisanalireza translationandvalidationoftheeortcbraincancermoduleeortcqlqbn20foruseiniran
AT yekaninejadmirsaeed translationandvalidationoftheeortcbraincancermoduleeortcqlqbn20foruseiniran
AT ardakanishahabkamali translationandvalidationoftheeortcbraincancermoduleeortcqlqbn20foruseiniran
AT pakpouramirh translationandvalidationoftheeortcbraincancermoduleeortcqlqbn20foruseiniran
AT mardaniazam translationandvalidationoftheeortcbraincancermoduleeortcqlqbn20foruseiniran
AT aaronsonneilk translationandvalidationoftheeortcbraincancermoduleeortcqlqbn20foruseiniran